QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.…
QT Imaging to Participate in the 17th Annual Craig-Hallum Alpha Select Conference
QT Imaging Holdings (QTI) Stock Sees Modest Fair Value Cut After Analyst Target Changes
QT Imaging Holdings (NASDAQ: QTI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 31 employees.
The shares were at 1.920 USD on 20 November 2026, down 69.9% over 52 weeks. Its 52-week range is 1.620 USD to 7.600 USD: the price is 74.7% below the high and 18.5% above the low.
Its market capitalisation is 28.21M USD.
QT Imaging Holdings reports return on equity of -327.1%, an operating margin of -24.9% and revenue up 75.1% year over year.
Its debt exceeds its cash by 8.62M USD, a debt-to-equity ratio of 0.81. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. The next earnings report is expected on 24 March 2027.